Zheng, Ze-Yi
Elsarraj, Hanan
Lei, Jonathan T.
Hong, Yan
Anurag, Meenakshi
Feng, Long
Kennedy, Hilda
Shen, Yichao
Lo, Flora
Zhao, Zifan
Zhang, Bing
Zhang, Xiang H.-F.
Tawfik, Ossama W.
Behbod, Fariba
Chang, Eric C.
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RR160027)
National Institutes of Health (R01CA207445, P50CA186784)
Cancer Research UK and KWF Kankerbestrijding (C38317/A24043)
The Kansas Institute for Precision Medicine – COBRE (P20 GM130423)
NCATS Frontiers-CTSA (UL1TR002366)
U.S. Department of Defense (W81XWH-21-1-0107)
Article History
Received: 7 August 2022
Accepted: 6 October 2022
First Online: 18 October 2022
Declarations
:
: Patients gave written informed consent for participation in this University of Kansas Medical Center Institutional Review Board approved study, which allowed collection of de-identified surgical tissue for research. The rest of the gene expression patient datasets are already published and publicly available.
: Our study does not contain any individual data, and all authors have approved the contents in this manuscript.
: All authors declared no conflict or personal or financial interests, except BZ who received personal fees from AstraZeneca and TNIK PHARMACEUTICALS LTD outside the submitted work.